MFX Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 42

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 15

MFX General Information

Description

Operator of a cell therapy research and manufacturing platform designed to make bio-processing scalable and affordable for cell and gene therapy. The company's platform specializes in tackling the problems of process control and scalability with cell bioprocessing in particular for autologous cell and gene therapy, enabling biologists to carry out process development by running cell culture conditions in parallel with extreme process control and to scale up cells for manufacturing at a lower cost.

Contact Information

Website
www.mfx.bio
Formerly Known As
MicrofluidX
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Stevenage Bioscience Catalyst
  • Gunnels Wood Road
  • Stevenage SG1 2FX
  • England, United Kingdom
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Biotechnology
Vertical(s)
Corporate Office
  • Stevenage Bioscience Catalyst
  • Gunnels Wood Road
  • Stevenage SG1 2FX
  • England, United Kingdom

MFX Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MFX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC 01-Jan-2026 Completed Generating Revenue
13. Accelerator/Incubator 01-Jun-2025 Completed Product In Beta Test
12. Accelerator/Incubator 01-Jan-2024 Completed Product In Beta Test
11. Later Stage VC 03-Sep-2024 Completed Product In Beta Test
10. Grant 19-Dec-2023 Completed Product In Beta Test
9. Early Stage VC 10-Oct-2023 Completed Product In Beta Test
8. Secondary Transaction - Private 01-Dec-2022 Completed Product In Beta Test
7. Early Stage VC 06-Apr-2022 Completed Startup
6. Grant 11-Jan-2022 $1.5M $1.78M Completed Startup
5. Secondary Transaction - Private 01-Mar-2021 $1.78M Completed Startup
To view MFX’s complete valuation and funding history, request access »

MFX Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferance Shares
Ordinary
Preferance Shares
Ordinary 968 $0.012278 $251.9 $251.9 1x $251.9 1.54%
Ordinary 22,360 $0.012278 $78.83 $78.83 1x $78.83 35.53%
To view MFX’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

MFX Patents

MFX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025233627-A2 Systems and methods for bioprocessing Pending 10-May-2024
WO-2025233627-A3 Systems and methods for bioprocessing Pending 10-May-2024
WO-2024246545-A1 Microfluidic chip and system for bioprocessing and method of use thereof Inactive 31-May-2023
WO-2024153916-A2 Systems and methods for aseptic connection Inactive 16-Jan-2023
WO-2024153916-A3 Systems and methods for aseptic connection Inactive 16-Jan-2023 C12M37/00
To view MFX’s complete patent history, request access »

MFX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MFX Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Southern Angel Investors Club Angel Group Minority
BioIndustry Association Accelerator/Incubator Minority
Grow London Accelerator/Incubator
AT8 Capital Partners Venture Capital Minority
Esco Lifesciences Group VC-Backed Company Minority
You’re viewing 5 of 15 investors. Get the full list »

MFX FAQs

  • When was MFX founded?

    MFX was founded in 2018.

  • Where is MFX headquartered?

    MFX is headquartered in Stevenage, United Kingdom.

  • What is the size of MFX?

    MFX has 42 total employees.

  • What industry is MFX in?

    MFX’s primary industry is Discovery Tools (Healthcare).

  • Is MFX a private or public company?

    MFX is a Private company.

  • What is MFX’s current revenue?

    The current revenue for MFX is .

  • How much funding has MFX raised over time?

    MFX has raised $19.3M.

  • Who are MFX’s investors?

    Southern Angel Investors Club, BioIndustry Association, Grow London, AT8 Capital Partners, and Esco Lifesciences Group are 5 of 15 investors who have invested in MFX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process